Rebecca Tran

Rebecca Tran is a seasoned professional in clinical operations with extensive leadership experience across various biopharmaceutical companies. Currently serving as Sr. Director of Clinical Operations at Candid Therapeutics since September 2024, Rebecca has previously held significant roles at Erasca, Inc., Gossamer Bio, Retrophin, TESARO, Inc., and Gilead Sciences, demonstrating a strong progression in responsibilities from Clinical Trial Manager to Sr. Director. Early career experience includes roles at Stanford University and Washington University in St. Louis as a Clinical Research Coordinator, as well as an IRB Administrator at BioMed IRB, and a Staff Research Associate at UC San Diego. Rebecca holds a Master of Science in Health Care Administration from Washington University in St. Louis and a Bachelor of Science in Human Biology from UC San Diego.